RR. Rolls-Royce Group PLC value of shares traded £209,695,492 BP. BP PLC value of shares traded £131,821,426 GLEN Glencore PLC value of shares traded £116,946,570 BLT BHP Billiton PLC value of shares traded £113,281,604 RIO Rio Tinto PLC …
Stock Market Wire · 13 hours ago
... (GSK). Additional information can be found at the company's website: Stock Market XML and JSON Data API provided by FinancialContent Services, Inc. Nasdaq quotes delayed at least 15 …
Financial Content · 1 day ago
stem cell
NEW YORK (TheStreet) -- GlaxoSmithKline (GSK - Get Report) shares are up 0.6% to $43.32 in pre-market trading on Monday after the healthcare company agreed to sell two of its meningitis vaccines to Pfizer (PFE) for $131 million today, according to the …
The Street · 6/22/2015
More from Bing News
GlaxoSmithKline ran four mid-stage studies about 5 years ... That may help explain why Axovant's stock slid slightly this morning, after the upbeat review hit.
Fierce Biotech · ByJohn Carroll · 1 day ago
Phase III
GSK was incorporated in 1971and got listed on the Nigerian Stock Exchange (NSE), in 1977. GSK United Kingdom controls 46.42 per cent of the company through Setfirst Limited and Smithkline Beecham Limited. The remaining 53.54 per cent shares are …
AllAfrica · 7/1/2015
The Company is now working with 18 of the top 20 global pharmaceutical companies including Merck, Pfizer and Novartis. GSK licensed from Codexis the CodeEvolver® directed evolution technology platform, which … · 6/26/2015
Stock futures are rising while European markets are mixed ... (Washington Post) China will receive cut-price supplies of GlaxoSmithKline's new HIV drug Tivicay, following a deal for Shanghai-based Desano …
Cleveland Plain Dealer · 7/2/2015
Stock futures
Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report GLAXOSMITHKLINE (GSK): Free Stock Analysis Report ELEVEN BIOTHERP (EBIO): Free Stock Analysis Report
Yahoo News · 1 day ago
Pfizer (NYSE:PFE) recently announced its decision to acquire two meningitis vaccines, Nimenrix and Mencevax, from GlaxoSmithKline (GSK) for $130 million. [1] Both vaccines are approved for commercial sales and the move builds upon Pfizer’s last …
Trefis · 7/1/2015
Health care giant GlaxoSmithKline (NYSE:GSK) is a company shrouded in controversy right now. It is reeling from a bribery scandal in China, and was recently fined $500 million for this. Investors have responded by selling the stock. GlaxoSmithKline is …
Seeking Alpha · 10/31/2014


GlaxoSmithKline plc is a British multinational pharmaceutical company headquartered in Brentford, London. It was the world'…
GlaxoSmithKline plc is a British multinational pharmaceutical company headquartered in Brentford, London. It was the world's sixth-largest pharmaceutical company in 2014, after Pfizer, Novartis, Sanofi, Hoffmann-La Roche and Merck. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham.
Data from: Wikipedia